This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Oct 5;355(14):1409-12.

doi: 10.1056/NEJMp068185.

The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration

Robert Steinbrook¹

Affiliations

PMID: 17021315
DOI: 10.1056/NEJMp068185

Comment

The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration

Robert Steinbrook. N Engl J Med. 2006.

. 2006 Oct 5;355(14):1409-12.

doi: 10.1056/NEJMp068185.

Author

Robert Steinbrook¹

Affiliation

¹ rsteinbrook@attglobal.net

PMID: 17021315
DOI: 10.1056/NEJMp068185

No abstract available

PubMed Disclaimer

Comment on

Ranibizumab for neovascular age-related macular degeneration.
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY; MARINA Study Group. Rosenfeld PJ, et al. N Engl J Med. 2006 Oct 5;355(14):1419-31. doi: 10.1056/NEJMoa054481. N Engl J Med. 2006. PMID: 17021318 Clinical Trial.
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S; ANCHOR Study Group. Brown DM, et al. N Engl J Med. 2006 Oct 5;355(14):1432-44. doi: 10.1056/NEJMoa062655. N Engl J Med. 2006. PMID: 17021319 Clinical Trial.

Similar articles

Treatment of exudative age-related macular degeneration: many factors to consider.
Olsen TW. Olsen TW. Am J Ophthalmol. 2007 Aug;144(2):281-3. doi: 10.1016/j.ajo.2007.05.005. Am J Ophthalmol. 2007. PMID: 17659955 Free PMC article. No abstract available.
Short-term effectiveness of intravitreal bevacizumab versus ranibizumab injections for patients with neovascular age-related macular degeneration.
Chang TS, Kokame G, Casey R, Prenner J, Feiner L, Anderson N. Chang TS, et al. Retina. 2009 Oct;29(9):1235-41. doi: 10.1097/IAE.0b013e3181b20eed. Retina. 2009. PMID: 19934818
Bevacizumab and ranibizumab. Bevacizumab and the inverse postcode lottery.
Harris MJ. Harris MJ. BMJ. 2010 Jul 13;341:c3718. doi: 10.1136/bmj.c3718. BMJ. 2010. PMID: 20627986 No abstract available.
Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration.
Abouammoh M, Sharma S. Abouammoh M, et al. Curr Opin Ophthalmol. 2011 May;22(3):152-8. doi: 10.1097/ICU.0b013e32834595d0. Curr Opin Ophthalmol. 2011. PMID: 21483262 Review.
Age-related macular degeneration.
Jager RD, Mieler WF, Miller JW. Jager RD, et al. N Engl J Med. 2008 Jun 12;358(24):2606-17. doi: 10.1056/NEJMra0801537. N Engl J Med. 2008. PMID: 18550876 Review. No abstract available.

See all similar articles

Cited by

Antivascular endothelial growth factor agents for neovascular age-related macular degeneration.
Zampros I, Praidou A, Brazitikos P, Ekonomidis P, Androudi S. Zampros I, et al. J Ophthalmol. 2012;2012:319728. doi: 10.1155/2012/319728. Epub 2011 Nov 19. J Ophthalmol. 2012. PMID: 22174998 Free PMC article.
Vascular endothelial growth factor expression and inhibition in uveal melanoma cell lines.
Logan P, Burnier J, Burnier MN Jr. Logan P, et al. Ecancermedicalscience. 2013 Jul 31;7:336. doi: 10.3332/ecancer.2013.336. Print 2013. Ecancermedicalscience. 2013. PMID: 23914254 Free PMC article.
Treatment of age-related macular degeneration: focus on ranibizumab.
Spitzer MS, Ziemssen F, Bartz-Schmidt KU, Gelisken F, Szurman P. Spitzer MS, et al. Clin Ophthalmol. 2008 Mar;2(1):1-14. doi: 10.2147/opth.s1959. Clin Ophthalmol. 2008. PMID: 19668384 Free PMC article.
Switching from intravitreal ranibizumab to bevacizumab for age-related macular degeneration.
Yamada K, Kimoto K, Kono H, Kubota T. Yamada K, et al. ISRN Ophthalmol. 2011 Dec 21;2011:916789. doi: 10.5402/2011/916789. eCollection 2011. ISRN Ophthalmol. 2011. PMID: 24555120 Free PMC article.
Informed consent and shared decision-making: a requirement to disclose to patients off-label prescriptions.
Wilkes M, Johns M. Wilkes M, et al. PLoS Med. 2008 Nov 11;5(11):e223. doi: 10.1371/journal.pmed.0050223. PLoS Med. 2008. PMID: 18998769 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information